Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
about
Expression of agrin, dystroglycan, and utrophin in normal renal tissue and in experimental glomerulopathiesNeph1 cooperates with nephrin to transduce a signal that induces actin polymerizationThree-dimensional architecture of podocytes revealed by block-face scanning electron microscopy.Glomerular function and morphology in puromycin aminonucleoside nephropathy in rats.Yi qi qing re gao attenuates podocyte injury and inhibits vascular endothelial growth factor overexpression in puromycin aminonucleoside rat model.Estrogen receptor alpha expression in podocytes mediates protection against apoptosis in-vitro and in-vivo.Focal and segmental glomerulosclerosis: clinical and kidney biopsy correlations.Podocyte process effacement in vivo.Retinoids as a potential treatment for experimental puromycin-induced nephrosis.Proteolytic processing of dynamin by cytoplasmic cathepsin L is a mechanism for proteinuric kidney disease.Following specific podocyte injury captopril protects against progressive long term renal damage.Tight junction biology and kidney dysfunction.Inducible rodent models of acquired podocyte diseases.Focal segmental glomerulosclerosis: towards a better understanding for the practicing nephrologist.Combined use of electron microscopy and intravital imaging captures morphological and functional features of podocyte detachment.Podocyte migration during nephrotic syndrome requires a coordinated interplay between cathepsin L and alpha3 integrin.Renoprotective effect of topiroxostat via antioxidant activity in puromycin aminonucleoside nephrosis ratsPodocin is translocated to cytoplasm in puromycin aminonucleoside nephrosis rats and in poor-prognosis patients with IgA nephropathy.Comparative anatomy of the podocyte: A scanning electron microscopic study.Close relations between podocyte injuries and membranous proliferative glomerulonephritis in autoimmune murine models.Con: Biomarkers in glomerular diseases: putting the cart before the wheel?Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte.Minimal change disease of the kidney in a young Sprague Dawley rat.
P2860
Q28344242-9E7B1113-10A3-40D7-831B-9D7A9651E726Q28594662-DB8BC547-51FA-47F5-9AD6-29CAD1C6AC11Q30626624-B23B9E24-CF65-4676-A4F3-979C7404814FQ31440703-B11C9FE3-9A87-4A9A-971B-35BE78F13570Q33748334-2B1C58C7-763A-487D-B2EB-4960236EA2F0Q34077911-58F21432-648E-4F8C-AD3C-576B989504EFQ34556394-1E3DDBB5-78C9-407A-8411-69DA77CA9ECFQ34638751-DDC21F6F-C152-45A4-B9DC-862447F26BDDQ35045441-DB9C4A18-D72C-40BB-91F9-BDF75B433104Q35916157-DDD98BD5-2EBB-4C89-A220-DAE83891B8E4Q36274488-4D376181-338A-4C17-956A-A496C3E90A1FQ36337194-AFE24386-BEFB-4C9A-B649-C391881AC16BQ37265903-E63760F1-A4B2-4CDC-9D97-2724F121AB58Q38192853-43BCCAD4-DE37-4332-AD20-8152443A603FQ39406342-5FB150F9-6402-44CE-8CFA-9C0491231B88Q40545315-8D7C429A-F9F6-44FA-8FE4-68AF57A48FB4Q41385892-B1EA8EE8-F11C-4CB2-834B-0F59BC8EFF13Q42135023-7002F220-EFD8-4AE8-B961-4C9389E284C5Q42521451-C09478C4-0783-4E5D-AEDC-1E671AC7FE32Q46345674-3924C1CC-704B-4F52-B936-FCB971710119Q53497916-8B09645B-3FDE-44EB-B3C6-97A8753E2063Q53634292-B13A3871-252E-4BDA-AB03-5BDE9B7D64B0Q55006245-7655E291-AFCC-4948-B811-47B529E265DE
P2860
Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
@en
Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
@nl
type
label
Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
@en
Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
@nl
prefLabel
Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
@en
Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
@nl
P2093
P356
P1433
P1476
Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis.
@en
P2093
P2888
P304
P356
10.1038/KI.1996.439
P407
P577
1996-10-01T00:00:00Z